Security key
78667J108
Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE)
CUSIP: 78667J108
Q4 2020 13F Holders as of 31 Dec 2020
- Type / Class
- Equity / Common Stock, par value $0.0001 per share (the "Common Stock")
- Shares outstanding
- 62,650,155
- Total 13F shares
- 53,803,776
- Share change
- +109,129
- Total reported value
- $4,654,671,800
- Put/Call ratio
- 97%
- Price per share
- $86.51
- Number of holders
- 244
- Value change
- +$61,838,572
- Number of buys
- 112
- Number of sells
- 115
Report period
Q4 2020
Institutions
244
Top holders
10
SAGE full security history
Newer quarter: Q1 2021
Previous quarter: Q3 2020
Sage Therapeutics, Inc. SEC filings
Sage Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 78667J108
Recent filing periods:
Top shareholders of SAGE - Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
12%
|
7,796,140
|
$476,500,000 | — | 30 Sep 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
7.2%
|
4,520,440
|
$276,290,000 | — | 30 Sep 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.8%
|
2,993,856
|
$182,985,000 | — | 30 Sep 2020 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
4.1%
|
2,559,034
|
$156,408,000 | — | 30 Sep 2020 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
3.9%
|
2,463,066
|
$150,543,000 | — | 30 Sep 2020 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
3.1%
|
1,966,688
|
$120,204,000 | — | 30 Sep 2020 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
2.6%
|
1,619,701
|
$98,995,000 | — | 30 Sep 2020 | |
| Bellevue Group AG |
13F
|
Company |
2.5%
|
1,579,504
|
$96,539,000 | — | 30 Sep 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
2.5%
|
1,536,076
|
$91,658,000 | — | 30 Sep 2020 | |
| Invesco Ltd. |
13F
|
Company |
2.4%
|
1,494,886
|
$91,367,000 | — | 30 Sep 2020 | |
| STATE STREET CORP |
13F
|
Company |
2.4%
|
1,488,399
|
$90,971,000 | — | 30 Sep 2020 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
2.3%
|
1,433,449
|
$87,612,000 | — | 30 Sep 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.3%
|
1,425,063
|
$87,100,000 | — | 30 Sep 2020 | |
| Boxer Capital, LLC |
13F
|
Company |
1.7%
|
1,094,000
|
$66,865,000 | — | 30 Sep 2020 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
1.7%
|
1,076,737
|
$65,810,000 | — | 30 Sep 2020 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.7%
|
1,050,000
|
$64,176,000 | — | 30 Sep 2020 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.5%
|
942,000
|
$57,575,000 | — | 30 Sep 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.96%
|
601,400
|
$36,757,000 | — | 30 Sep 2020 | |
| Palo Alto Investors LP |
13F
|
Company |
0.94%
|
590,200
|
$36,073,000 | — | 30 Sep 2020 | |
| NORGES BANK |
13F
|
Company |
0.9%
|
565,633
|
$34,571,000 | — | 30 Sep 2020 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
0.89%
|
555,473
|
$33,951,000 | — | 30 Sep 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.85%
|
533,235
|
$32,591,000 | — | 30 Sep 2020 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.85%
|
531,399
|
$32,479,000 | — | 30 Sep 2020 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
0.8%
|
499,100
|
$30,505,000 | — | 30 Sep 2020 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.71%
|
445,375
|
$27,221,319 | — | 30 Sep 2020 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.7%
|
438,365
|
$26,793,000 | — | 30 Sep 2020 | |
| Marshall Wace North America L.P. |
13F
|
Company |
0.67%
|
421,939
|
$25,789,000 | — | 30 Sep 2020 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.62%
|
389,996
|
$23,827,000 | — | 30 Sep 2020 | |
| Vivo Capital, LLC |
13F
|
Company |
0.56%
|
353,511
|
$21,607,000 | — | 30 Sep 2020 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.5%
|
313,545
|
$19,164,000 | — | 30 Sep 2020 | |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. |
13F
|
Company |
0.5%
|
313,347
|
$19,151,769 | — | 30 Sep 2020 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.48%
|
302,214
|
$18,471,000 | — | 30 Sep 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.48%
|
299,437
|
$18,301,000 | — | 30 Sep 2020 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.44%
|
274,837
|
$16,798,000 | — | 30 Sep 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.42%
|
265,729
|
$16,241,000 | — | 30 Sep 2020 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.41%
|
258,819
|
$15,819,000 | — | 30 Sep 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.41%
|
255,889
|
$15,640,000 | — | 30 Sep 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.41%
|
253,751
|
$15,509,000 | — | 30 Sep 2020 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.4%
|
251,082
|
$15,346,000 | — | 30 Sep 2020 | |
| Logos Global Management LP |
13F
|
Company |
0.4%
|
250,000
|
$15,280,000 | — | 30 Sep 2020 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.38%
|
238,508
|
$14,578,000 | — | 30 Sep 2020 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.37%
|
230,000
|
$14,058,000 | — | 30 Sep 2020 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.36%
|
225,000
|
$13,752,000 | — | 30 Sep 2020 | |
| AMUNDI ASSET MANAGEMENT US, INC. |
13F
|
Company |
0.36%
|
223,133
|
$13,638,000 | — | 30 Sep 2020 | |
| Artal Group S.A. |
13F
|
Company |
0.35%
|
222,300
|
$13,587,000 | — | 30 Sep 2020 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.35%
|
221,042
|
$13,510,000 | — | 30 Sep 2020 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.35%
|
220,004
|
$13,447,000 | — | 30 Sep 2020 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.33%
|
206,918
|
$12,643,000 | — | 30 Sep 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.33%
|
206,751
|
$12,637,000 | — | 30 Sep 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.33%
|
203,710
|
$12,450,000 | — | 30 Sep 2020 |
Institutional Holders of Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) as of Q4 2020
As of 31 Dec 2020,
Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) was held by
244 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
53,803,776 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, D. E. Shaw & Co., Inc., JANUS HENDERSON GROUP PLC, Artisan Partners Limited Partnership, Bellevue Group AG, and STATE STREET CORP.
This page lists
245
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2020 vs Q3 2020 Across Filers
Q3 2020 holders
224
Q4 2020 holders
244
Holder diff
20
| Investor | Q3 2020 Shares | Q4 2020 Shares | Share Diff | Share Chg % | Q3 2020 Value $ | Q4 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.